In conclusion, CD90+ fibroblasts induce angiogenesis in physiological processes and the tumor microenvironment by secreting relevant effector cytokines in combination with vascular endothelial cells, which has great application prospects for clinical regenerative medicine and tumor targeting therapy. Here, THY1 is linked to neoplasm.